Feed/Investors/Angelini Industries

Angelini Industries

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Corporationangeliniindustries.comSince 2026-10-19

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$135.0M

across 1 round

LATEST ROUND

Series D · $135.0M · 2026-10-19

CO-INVESTORS

named beside it

Rounds

The rounds this investor is named on, who it invests beside, and where it shows up.

Nouscom[ PART ]

A clinical-stage, cancer interception focused biotech developing next-generation immunotherapies

Series D$135.0M2026-10-1915

Company	Round	Amount	Announced	Role
Nouscom A clinical-stage, cancer interception focused biotech developing next-generation immunotherapies	Series D Verified against 4 of 15 sources	$135.0M	2026-10-19	[ PART ]